Literature DB >> 227345

The effect of pyrophosphate analogues on influenza virus RNA polymerase and influenza virus multiplication.

S Stridh, E Helgstrand, B Lannerö, A Misiorny, G Stening, B Oberg.   

Abstract

Analogues of pyrophosphate have been tested as inhibitors of influenza virus-RNA polymerase activity in cell-free assays. The most active compound, phosphonoformic acid (PFA), reduced the polymerase activity to 50 per cent at a concentration of 20 muM. The inhibition was dependent on the type of divalent cation present in the assay. PFA at a concentration of 400 muM also inhibited the influenza virus plaque formation by 90 per cent.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 227345     DOI: 10.1007/bf01318059

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  12 in total

1.  A strategy for the chemotherapy of infectious disease.

Authors:  S S Cohen
Journal:  Science       Date:  1977-07-29       Impact factor: 47.728

2.  Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate.

Authors:  J M Reno; L F Lee; J A Boezi
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

3.  Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate.

Authors:  B Eriksson; E Helgstrand; N G Johansson; A Larsson; A Misiorny; J O Norén; L Philipson; K Stenberg; G Stening; S Stridh; B Oberg
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

4.  Animal DNA-dependent RNA polymerases. 1. Large-scale solubilization and separation of A and B calf-thymus RNA-polymerase activities.

Authors:  C Kedinger; F Gissinger; M Gniazdowski; J L Mandel; P Chambon
Journal:  Eur J Biochem       Date:  1972-07-13

5.  Globin mRNAs are primers for the transcription of influenza viral RNA in vitro.

Authors:  M Bouloy; S J Plotch; R M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

6.  A simple plaque assay for influenza A 2 viruses and its application to antiviral screening.

Authors:  J Bentley; E A Wickham
Journal:  Arch Gesamte Virusforsch       Date:  1971

7.  Segments of influenza virus complementary RNA synthesized in vitro.

Authors:  S J Plotch; R M Krug
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

8.  Influenza virion transcriptase: synthesis in vitro of large, polyadenylic acid-containing complementary RNA.

Authors:  S J Plotch; R M Krug
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

9.  Transcription of the influenza ribonucleic acid genome by a virion polymerase. I. Optimal conditions for in vitro activity of the ribonucleic acid-dependent ribonucleic acid polymerase.

Authors:  D H Bishop; J F Obijeski; R W Simpson
Journal:  J Virol       Date:  1971-07       Impact factor: 5.103

10.  Trisodium phosphonoformate inhibits hepatitis B Dane particle DNA polymerase.

Authors:  E Nordenfelt; E Helgstrand; B Oberg
Journal:  Acta Pathol Microbiol Scand B       Date:  1979-02
View more
  3 in total

1.  The inhibition of the RNA polymerase activity of influenza virus A by pyrophosphate analogues.

Authors:  P A Cload; D W Hutchinson
Journal:  Nucleic Acids Res       Date:  1983-08-25       Impact factor: 16.971

Review 2.  Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infection.

Authors:  Jairam R Lingappa; Connie Celum
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Differential inhibition of DNA polymerase and RNase H activities of the reverse transcriptase by phosphonoformate.

Authors:  M Margalith; H Falk; A Panet
Journal:  Mol Cell Biochem       Date:  1982-03-19       Impact factor: 3.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.